CLINICAL_TRIALS
research
· 2014-09-11
Clinical Trial Update: Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins [Phase 2, Phase 3]
Summary
A Phase 2/3 clinical trial update studying anti-Mullerian hormone (AMH) levels during ovarian stimulation with gonadotropins in infertility.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Athens | Conditions: Female Infertility | Phase 2, Phase 3 | Status: UNKNOWN